Concepedia

Tina Branscombe Miranda

TB

Statistics

Publications

18

Citations

2.9K

H-Index

17

Active since

2004

Affiliations

National Cancer Institute(Current)

University of California, Los Angeles

University of Southern California

University of Washington

National Institutes of Health

Tina Branscombe Miranda is an author at National Cancer Institute specializing in molecular biology, life sciences, and epigenetics.

ORCID

Publications per year

2004–2016

18

Publications

18

DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation

Tina Branscombe Miranda, Connie C. Cortez, Christine B. Yoo et al. · Molecular Cancer Therapeutics · 2009 · 597 citations · Full text

, , +16

Transcription Factor AP1 Potentiates Chromatin Accessibility and Glucocorticoid Receptor Binding

Simon C. Biddie, Sam John, Pete J. Sabo et al. · Molecular Cell · 2011 · 501 citations · Full text

, , +12

Steroid Receptors Reprogram FoxA1 Occupancy through Dynamic Chromatin Transitions

Erin E. Swinstead, Tina Branscombe Miranda, Ville Paakinaho et al. · Cell · 2016 · 333 citations · Full text

, , +14

Dynamic Exchange at Regulatory Elements during Chromatin Remodeling Underlies Assisted Loading Mechanism

Ty C. Voss, R. Louis Schiltz, Myong‐Hee Sung et al. · Cell · 2011 · 310 citations · Full text

, , +12

PRMT7 Is a Member of the Protein Arginine Methyltransferase Family with a Distinct Substrate Specificity

Tina Branscombe Miranda, Mark Miranda, Adam Frankel et al. · Journal of Biological Chemistry · 2004 · 195 citations · Full text

, , +12

1–5 of 18